<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">IJOHNS</journal-id><journal-title-group><journal-title>International Journal of Otolaryngology and Head &amp; Neck Surgery</journal-title></journal-title-group><issn pub-type="epub">2168-5452</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ijohns.2021.102009</article-id><article-id pub-id-type="publisher-id">IJOHNS-107558</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Dermatofibrosarcoma Protuberans of the Neck: A Case Report
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tzu-I</surname><given-names>Wu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hsing-Mei</surname><given-names>Wu</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yih-Jeng</surname><given-names>Tsai</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tzu</surname><given-names>Hsuan Luo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chia-Jung</surname><given-names>Lee</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Otolaryngology Head and Neck Surgery, Shin Kong Wu-Ho-Su Memorial Hospital, Taiwan</addr-line></aff><aff id="aff2"><addr-line>School of Medicine, Fu-Jen Catholic University, Taiwan</addr-line></aff><pub-date pub-type="epub"><day>10</day><month>03</month><year>2021</year></pub-date><volume>10</volume><issue>02</issue><fpage>85</fpage><lpage>91</lpage><history><date date-type="received"><day>12,</day>	<month>January</month>	<year>2021</year></date><date date-type="rev-recd"><day>1,</day>	<month>March</month>	<year>2021</year>	</date><date date-type="accepted"><day>4,</day>	<month>March</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Dermatofibrosarcoma protuberans (DFSP) is rare soft tissue sarcoma but has a locally aggressive nature. Although most cases are of low grade and have a rare metastasis rate, all DFSP variants have a tendency to show local recurrence. Wide excision with negative margins is the treatment of choice. 
  Aim: To report a case of DFSP who presented with an asymptomatic slow growing tumor similar to etiologies such as hypertrophic scars or other benign soft tissue tumors. 
  Case Presentation: A 68-year-old male presented with a large soft tumor located at the left posterior neck. Local excision was done under the preoperative impression of a benign tumor such as lipoma or sebaceous cyst. However the diagnosis of DFSP was made upon histological examination and the patient underwent another surgery to achieve free resection margins under general anesthesia as well as adjuvant radiotherapy. 
  Conclusion: DFSP is a malignant tumor that is diagnosed histopathologically. Due to the low incidence rate, slow-growing nature, and non-alarming initial presentation features, diagnostic delay or even misdiagnosis is not uncommon.
 
</p></abstract><kwd-group><kwd>Dermatofibrosarcoma Protuberans</kwd><kwd> Soft Tissue Sarcoma</kwd><kwd> Surgery</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Dermatofibrosarcoma protuberans (DFSP) is an uncommon locally aggressive cutaneous soft tissue sarcoma of the dermis layer of the skin [<xref ref-type="bibr" rid="scirp.107558-ref1">1</xref>] with an incidence of 0.8 - 4.5 cases per million per year [<xref ref-type="bibr" rid="scirp.107558-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.107558-ref3">3</xref>]. Approximately 85 to 90 percent of DFSPs are low grade. Despite its rare metastasis rate (&lt;5%), all DFSP variants have a tendency to show local recurrence [<xref ref-type="bibr" rid="scirp.107558-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.107558-ref5">5</xref>]. Most commonly occurring in adult patients in their thirties, DFSP accounts for approximately 1% - 6% of soft tissue sarcoma cancers [<xref ref-type="bibr" rid="scirp.107558-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.107558-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.107558-ref7">7</xref>]. More than 90% of DFSP tumors have rearrangement of chromosome 17 and 22 that fuses collagen gene COL1A1 with platelet-derived growth factor (PDGF), leading to transcriptional up-regulation of PDGF and thus established a self-stimulatory growth signal [<xref ref-type="bibr" rid="scirp.107558-ref7">7</xref>]. Immunoreactivity for CD34 in DFSP was described in 1993 and remains to be the main immunohistochemical marker for diagnosing DFSP [<xref ref-type="bibr" rid="scirp.107558-ref7">7</xref>]. Due to its slow growing nature similar to nodules that appear as hypertrophic scars or benign soft tissue tumors without any definite symptoms, it is difficult to diagnose pre-operatively. The preferred initial treatment for a localized dermatofibrosarcoma protuberans (DFSP) is resection with pathologically negative margins. However, extensive excision may not be feasible due to either anatomic limitation or cosmetic concerns, especially if found in the head and neck region. A case requiring an additional surgery and adjuvant radiotherapy, due to difficulty of an accurate preoperative diagnosis and tumor location, is reported here.</p></sec><sec id="s2"><title>2. Case Report</title><p>A 68-year-old Taiwanese man visited our clinic due to noticing a left posterior neck mass for 6 months. The patient reported progressive growth of the tumor in size during the preceding six months. The patient denied any recent weight loss, fever, night sweats or chills. On physical examination, the mass measured about 2.0 &#215; 2.0 cm over the patient’s left posterior neck, and it was firm, painless, with no sign of localized heat or erythematous change, and relatively movable. The patient’s neck was supple, with no palpable cervical lymphadenopathies. The patient denied past history of malignancy. A neck sonography exam was performed, and a well-defined, heterogeneous subcutaneous tumor was noted, measuring 1.58 &#215; 0.92 cm, with posterior enhancement (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Under the impression of a posterior neck lipoma or sebaceous cyst, the patient underwent excisional biopsy under local anesthesia on an outpatient basis. Gross tumor was completely removed, but an infiltrative nature was noted around the border without a well-defined margin. Upon histological examination, infiltrating and hypercellular tumor composed of interlacing fascicles of hyperchromatic atypical spindle cells arranged in vague storiform fashion was described (<xref ref-type="fig" rid="fig2">Figure 2</xref>), as well as abnormal mitotic figures average 4 per 10 HPFs noted. Special stain showed tumor cells are immunoreactive against antibody to CD34 (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Based on the histological and immunohistochemical findings, the diagnosis of dermatofibrosarcoma was made. The patient underwent an additional wide excision under general anesthesia. Due to lack of gross tumor, the wide excision was focused to encompass the whole previous surgical site with resection margins checked intra-operatively via frozen section pathologic review. Although the histopathology report revealed free margins and only few atypical spindle cells present in the specimen, the surgeon felt that resection of an adequate margin could not be achieved, especially the deep margin, due to the location of the tumor being at the neck. The patient underwent adjuvant local radiotherapy treatment with a total radiation dose of 66 Gy in 33 fractions. The patient currently has no signs of local recurrence 12 months after surgery, and is under regular follow-up with sonography exam (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec><sec id="s3"><title>3. Discussion</title><p>In the early stages, it is difficult to differentiate DFSP from other benign subcutaneous lesions such as lipomas, epidermal cysts, keloids, or dermatofibroma without undergoing surgical excision and histology examination. DFSP often presents as a minor skin firm area. It commonly resembles a bruise or pimple, and is a slow growing tumor. The most common location of DFSP is the trunk (42% - 72%) followed by proximal extremities (20% - 30%), with head and neck region being the least (10% - 16%) [<xref ref-type="bibr" rid="scirp.107558-ref8">8</xref>].</p><p>With sonography, DFSPs have been found to be around (67%) or ovoid (33%) subcutaneous lesion that are mostly well defined (89%) [<xref ref-type="bibr" rid="scirp.107558-ref9">9</xref>]. Appearance of DFSP usually involves a mildly lobulated border and a heterogeneously hypoechoic matrix. Posterior enhancement can also usually be noted [<xref ref-type="bibr" rid="scirp.107558-ref9">9</xref>]. Vascularity of DFSP, which is a marker of malignancy, varies as well. Since lipomas may also present with similar features, a distinction is not always possible. Hence, an initial preoperative impression of a benign lesion such as sebaceous cyst or lipoma was made for our case, which led to additional surgery and adjuvant treatment. Several authors have reported benefits of utilizing magnetic resonance imaging (MRI) preoperatively to better evaluate tumor extent [<xref ref-type="bibr" rid="scirp.107558-ref10">10</xref>]. In cases of large tumors (&gt;4 cm in diameter), MRI is able to aid clinicians in distinguishing the relationship of the tumor with surrounding structures [<xref ref-type="bibr" rid="scirp.107558-ref11">11</xref>].</p><p>Definite diagnosis of DFSP requires histopathological examination. In order to ensure adequate tissue for examination, biopsy should be performed with a core-needle or surgical incision [<xref ref-type="bibr" rid="scirp.107558-ref12">12</xref>]. Microscopically, DFSP infiltrates the dermis diffusely, while often sparing the epidermis and skin. Kim et al. described seven histological DFSP subtypes, with “classic” DFSP comprising about 90% 13. The “classic” subtype of DFSP has histological characteristics of monomorphous fusiform cells (spindle cells) and a large elongated nucleus and a low mitotic index. These spindle cells are irregularly organized with a storiform arrangement [<xref ref-type="bibr" rid="scirp.107558-ref13">13</xref>]. Due to its tendency to invade surrounding tissue from a central lesion, DFSP has projections that show a honeycomb (30%) or multilayered (70%) subcutaneous pattern [<xref ref-type="bibr" rid="scirp.107558-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.107558-ref15">15</xref>]. DFSP typically shows positive staining for vimentin, CD34, apolipoprotein D, and nestin on immunohistochemistry [<xref ref-type="bibr" rid="scirp.107558-ref16">16</xref>].</p><p>DFSP is a low-grade malignancy, but has been reported a local recurrence rate up to 60% that may be attributed to incomplete excision due to poor circumscription and irregular boundaries [<xref ref-type="bibr" rid="scirp.107558-ref17">17</xref>]. Wide excision with 2 - 4 cm safe margin remains the cornerstone of the treatment of DFSP [<xref ref-type="bibr" rid="scirp.107558-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.107558-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.107558-ref19">19</xref>]. Although a sufficient excision margin is the key to reduce the local recurrence rate, it is often limited by the anatomical site, and the lesion typically infiltrates well beyond its grossly visible margin into the surrounding tissue. The use of Mohs micrographic surgery with incremental excision until normal tissue is obtained, as documented by repeat frozen sections, has been favored as the treatment of choice by some authors [<xref ref-type="bibr" rid="scirp.107558-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.107558-ref21">21</xref>].</p><p>Given that metastases to lymph nodes are extremely rare, there is no role for prophylactic regional node dissection. Radiotherapy (RT) is a noninvasive adjuvant treatment that can improve local control in patients, especially those having close or positive margins and re-excision not feasible. Several studies have suggested post-operative adjuvant RT reduced recurrence rate. A retrospective study of 184 patients reported a significant 5-year disease-free survival improvement in patients receiving adjuvant RT compared with patients that did not (88.1% vs 56.2%, P = 0.044) [<xref ref-type="bibr" rid="scirp.107558-ref22">22</xref>]. In our case, re-excision surgery was done after the diagnosis was made in an effort to achieve free and adequate resection margins. Although free surgical margin was reported, a wide safe margin was not feasible due to the location of the tumor, and adjuvant RT was utilized to improve local control. For DFSP patients with inoperable or metastatic diseases, Imatinib therapy is currently the standard of care. This targeted therapy may also potentially facilitate resection or decrease possible disfigurement when used in a neoadjuvant fashion [<xref ref-type="bibr" rid="scirp.107558-ref23">23</xref>].</p></sec><sec id="s4"><title>4. Conclusion</title><p>DFSP is a rare locally aggressive malignant soft tissue sarcoma that originates from the dermis layer of the skin. Diagnostic delay or even misdiagnosis is not uncommon due to its indolent nature. DFSP is diagnosed by histopathology examination; therefore a biopsy or at least a core-needle biopsy is required in order to ensure adequate tissue specimen is obtained. Wide excision with negative margins is the treatment of choice. For patients with close or positive surgical margins, RT is a noninvasive adjuvant treatment that improves local control.</p></sec><sec id="s5"><title>Acknowledgements</title><p>This research received no specific grant from any funding agency, commercial or not-for-profit sectors.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Wu, T.-I, Wu, H.-M., Tsai, Y.-J., Luo, T.H. and Lee, C.-J. (2021) Dermatofibrosarcoma Protuberans of the Neck: A Case Report. International Journal of Otolaryngology and Head &amp; Neck Surgery, 10, 85-91. https://doi.org/10.4236/ijohns.2021.102009</p></sec></body><back><ref-list><title>References</title><ref id="scirp.107558-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Eguzo, K., Camazine, B. and Milner, D. (2014) Giant Dermatofibrosarcoma Protuberans of the Face and Scalp: A Case Report. International Journal of Dermatology, 53, 767-772. https://doi.org/10.1111/j.1365-4632.2012.05639.x</mixed-citation></ref><ref id="scirp.107558-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Bhambri, S., Desai, A., Del Rosso, J.Q. and Mobini, N. (2008) Dermatofibrosarcoma Protuberans: A Case Report and Review of the Literature. Journal of Clinical and Aesthetic Dermatology, 1, 34-36.</mixed-citation></ref><ref id="scirp.107558-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Criscione, V.D. and Weinstock, M.A. (2007) Descriptive Epidemiology of dermatofibrosarcoma Protuberans in the United States, 1973 to 2002. Journal of the American Academy of Dermatology, 56, 968-973. https://doi.org/10.1016/j.jaad.2006.09.006</mixed-citation></ref><ref id="scirp.107558-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Dim-Jamora, K.C. and Perone, J.B. (2008) Management of Cutaneous Tumors with Mohs Micrographic Surgery. Seminars in Plastic Surgery, 22, 247-256.https://doi.org/10.1055/s-0028-1095884</mixed-citation></ref><ref id="scirp.107558-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Ratner, D., Thomas, C.O., Johnson, T.M., Sondak, V.K., Hamilton, T.A., Nelson, B.R., et al. (1997) Mohs Micrographic Surgery for the Treatment of Dermatofibrosarcoma Protuberans. Results of a Multiinstitutional Series with an Analysis of the Extent of Microscopic Spread. Journal of the American Academy of Dermatology, 37, 600-613. https://doi.org/10.1016/S0190-9622(97)70179-8</mixed-citation></ref><ref id="scirp.107558-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Du, K., Li, J., Tang, L., Lin, X., Kong, X., Liao, X., Peng, Q., Dong, Y., He, J., Huang, Y., Zhang, X., Lin, F., Zhuang, Q. and Wu, J. (2019) Role of Postoperative Radiotherapy in Dermatofibrosarcoma Protuberans: A Propensity Score-Matched Analysis. Radiation Oncology, 14, Article No. 20. https://doi.org/10.1186/s13014-019-1226-z</mixed-citation></ref><ref id="scirp.107558-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Lemm, D., Mügge, L.O., Mentzel, T. and H&amp;#246;ffken, K. (2009) Current Treatment Options in Dermatofibrosarcoma Protuberans. Journal of Cancer Research and Clinical Oncology, 135, 653-665. https://doi.org/10.1007/s00432-009-0550-3</mixed-citation></ref><ref id="scirp.107558-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Stojadinovic, A., Karpoff, H.M., Antonescu, C.R., Shah, J.P., Singh, B., Spiro, R.H., et al. (2000) Dermatofibrosarcoma Protuberans of the Head and Neck. Annals of Surgical Oncology, 7, 696-704. https://doi.org/10.1007/s10434-000-0696-3</mixed-citation></ref><ref id="scirp.107558-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Dubay, D., Cimmino, V., Lowe, L., Johnson, T.M. and Sondak, V.K. (2010) Low Recurrence Rate after Surgery for Dermatofibrosarcoma Protuberans: A Multidisciplinary Approach from a Single Institution. Cancer, 100, 1008-1016.https://doi.org/10.1002/cncr.20051</mixed-citation></ref><ref id="scirp.107558-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Chang, C.K., Jacobs, I.A. and Salti, G.I. (2004) Outcomes of Surgery for Dermatofibrosarcoma Protuberans. European Journal of Surgical Oncology, 30, 341-345.https://doi.org/10.1016/j.ejso.2003.12.005</mixed-citation></ref><ref id="scirp.107558-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Paramythiotis, D., Stavrou, G., Panagiotou, D., Petrakis, G. and Michalopoulos, A. (2016) Dermatofibrosarcoma Protuberans: A Case Report and Review of the Literature. Hippokratia, 20, 80-83.</mixed-citation></ref><ref id="scirp.107558-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Zelger, B.W., Ofner, D. and Zelger, B.G. (1995) Atrophic Variants of Dermatofibroma and Dermatofibrosarcoma Protuberans. Histopathology, 26, 519-527.https://doi.org/10.1111/j.1365-2559.1995.tb00270.x</mixed-citation></ref><ref id="scirp.107558-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Kamino, H. and Jacobson, M. (1990) Dermatofibrome Extending into the Subcutaneous Tissu: Differential Diagnosis from Dermatofibrosarcoma Protuberans. The American Journal of Surgical Pathology, 14, 1156-1164.</mixed-citation></ref><ref id="scirp.107558-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Kim, G.K. (2011) Status Report on the Management of Dermatofibrosarcoma Protuberans: Is There a Viable Role for the Use of Imatinib Mesylate? In Which Cases May It Be Therapeutically Helpful and in Which Cases Not? Journal of Clinical and Aesthetic Dermatology, 4, 17-26.</mixed-citation></ref><ref id="scirp.107558-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">National Comprehensive Cancer Network (2019) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines&lt;sup&gt;TM&lt;/sup&gt;) Dermatofibrosarcoma Protuberans Version 1. https://www.nccn.org/professionals/physician_gls/PDF/dfsp.pdf</mixed-citation></ref><ref id="scirp.107558-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Riggs, K., McGuigan, K.L., Morrison, W.B., Samie, F.H. and Humphreys, T. (2009) Role of Magnetic Resonance Imaging in Perioperative Assessment of Dermatofibrosarcoma Protuberans. Dermatologic Surgery, 35, 2036-2041.https://doi.org/10.1111/j.1524-4725.2009.01330.x</mixed-citation></ref><ref id="scirp.107558-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Torregiani, W.C., Al-Ismail, K., Munk, P., Nicolaou, S., O’Connell, J.X. and Knowling, M.A. (2002) Dermatofibrosarcoma Protuberans: MR Imaging Features. American Journal of Roentgenology, 178, 989-993.https://doi.org/10.2214/ajr.178.4.1780989</mixed-citation></ref><ref id="scirp.107558-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Shin, Y.R., Kim, J.Y., Sung, M.S. and Jung, J.H. (2008) Sonographic Findings of Dermatofibrosarcoma Protuberans with Pathologic Correlation. Journal of Ultrasound in Medicine, 27, 269-274. https://doi.org/10.7863/jum.2008.27.2.269</mixed-citation></ref><ref id="scirp.107558-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Stivala, A., Lombardo, G.A., Pompili, G., Tarico, M.S., Fraggetta, F. and Perrotta, R.E. (2012) Dermatofibrosarcoma Protuberans: Our Experience of 59 Cases. Oncology Letters, 4, 1047-1055. https://doi.org/10.3892/ol.2012.887</mixed-citation></ref><ref id="scirp.107558-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Llombart, B., Serra-Guillén, C., Monteagudo, C., López Guerrero, J.A. and Sanmartín, O. (2013) Dermatofibrosarcoma Protuberans: A Comprehensive Review and Update on Diagnosis and Management. Seminars in Diagnostic Pathology, 30, 13-28. https://doi.org/10.1053/j.semdp.2012.01.002</mixed-citation></ref><ref id="scirp.107558-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Kransdorf, M.J. (1995) Malignant Soft-Tissue Tumors in a Large Referral Population: Distribution of Diagnoses by Age, Sex, and Location. American Journal of Roentgenology, 164, 129-134. https://doi.org/10.2214/ajr.164.1.7998525</mixed-citation></ref><ref id="scirp.107558-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Sanmartín, O., Llombart, B., López-Guerrero, J.A., Serra, C., Requena, C. and Guillén, C. (2007) Dermatofibrosarcoma Protuberans [Dermatofibrosarcoma Protuberans]. Actas Dermo-Sifiliográficas, 98, 77-87. https://doi.org/10.1016/S0001-7310(07)70019-4</mixed-citation></ref><ref id="scirp.107558-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">McArthur, G. (2007) Dermatofibrosarcoma Protuberans: Recent Clinical Progress. Annals of Surgical Oncology, 14, 2876-2886.https://doi.org/10.1245/s10434-007-9480-y</mixed-citation></ref></ref-list></back></article>